Equity Capital Markets

Company · CIK 1421876

Lakefront Biotherapeutics NV

CIK1421876 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inC9
ListedLKFT (Nasdaq), GLPGF (OTC)
First annual or quarterly report2016-03-25

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-203435
IPOFinal prospectus
 2015-04-152015-05-148

Filings

15
FiledFilingRegistrationAccession
2018-09-14424B5Shelf takedown 333-2117650001193125-18-274167
2018-09-13424B5Shelf takedown 333-2117650001193125-18-272004
2017-04-18424B5Shelf takedown 333-2117650001193125-17-127404
2017-04-17424B5Shelf takedown 333-2117650001193125-17-126063
2015-05-14424B4Final prospectus 333-2034350001193125-15-188319
2015-05-13EFFECTDeclared effective 333-2034359999999995-15-001324
2015-05-12F-1/AAmendment 333-2034350001193125-15-184144
2015-05-11F-1/AAmendment 333-2034350001193125-15-182283
2015-05-07F-1/AAmendment 333-2034350001193125-15-175119
2015-05-05F-1/AAmendment 333-2034350001193125-15-172419
2015-04-30EFFECTDeclared effective 333-2035849999999995-15-001103
2015-04-30F-1/AAmendment 333-2034350001193125-15-162780
2015-04-15F-1Registration filed 333-2034350001193125-15-131365
2015-02-06DRSDraft made public 377-009170000950123-15-001042
2008-03-11EFFECTDeclared effective 333-1495909999999995-08-000762

All filings of this company · CSV